Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico (Q30405652)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

Armando Isibasi

4

object named as

Armando Isibasi

0 references

Constantino López-Macías

1

object named as

Constantino López-Macías

0 references

Eduardo Ferat-Osorio

2

object named as

Eduardo Ferat-Osorio

0 references

14

object named as

Gale Smith

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

author name string

Constantino López-Macías

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Eduardo Ferat-Osorio

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Alejandra Tenorio-Calvo

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Armando Isibasi

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Juan Talavera

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Oscar Arteaga-Ruiz

6

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Lourdes Arriaga-Pizano

7

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Somia P Hickman

8

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

María Allende

9

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Kathy Lenhard

10

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Steven Pincus

11

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Kevin Connolly

12

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Ramadevi Raghunandan

13

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Gregory Glenn

15

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

2 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

7826-7834

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

Baculovirus-expressed influenza vaccine. A novel technology for safe and expeditious vaccine production for human use.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

Swine flu. After delays, WHO agrees: the 2009 pandemic has begun

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials World Health Organization, Geneva, Switzerland, 17-18 February 2010.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

Safety and effectiveness of a 2009 H1N1 vaccine in Beijing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

Planning for the next influenza H1N1 season: a modelling study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

The 2009 A (H1N1) influenza virus pandemic: A review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

Response to a monovalent 2009 influenza A (H1N1) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

A novel influenza A (H1N1) vaccine in various age groups.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

Marketing paediatric influenza vaccination: results of a major metropolitan trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.099

7 January 2021

Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21816199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VACCINE.2011.07.099

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30405652&oldid=1975408510"